Company intelligence / Profile preview

ABbiotek Health

Ownership: Private
Development stage: Commercial

Overview

ABbiotek Health commercializes several microbiome- and enzyme-based products (mainly as postbiotics and supplements) targeting gut, immune, metabolic, mobility, CNS, and women's health. No prescription drugs or conventional clinical trial products; evidence is based on nutritional/functional food studies[1][3].

Therapeutic areas: Metabolic DisordersImmunologyGastroenterologyNeurologyWomen's HealthRheumatology
Modalities: Fermentation productsPostbioticEnzymeMicrobial therapy
Industry: Non-Drug Biotech

Drug pipeline

4 assets

ABB C1

Commercial

Indications: Immune system support

3 more assets in the full pipeline.

Request access →

Partnerships

Partnerships with pharma, food & beverage, and consumer health brands[1]Collaboration with Tetra Pak for postbiotic food and drinks[3]

Beyond the preview

Go deeper on ABbiotek Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ABbiotek Health.

Explore the full profile